Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyridazines | 1 | 2024 | 8 | 0.880 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 86 | 0.800 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 171 | 0.770 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 2011 | 2 | 0.440 |
Why?
|
| Thyroid Hormones | 2 | 2011 | 78 | 0.380 |
Why?
|
| Hypothyroidism | 3 | 2011 | 43 | 0.370 |
Why?
|
| Carcinoma, Medullary | 1 | 2010 | 2 | 0.340 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2010 | 9 | 0.330 |
Why?
|
| Postoperative Care | 1 | 2010 | 123 | 0.320 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 74 | 0.320 |
Why?
|
| Thyroxine | 2 | 2024 | 54 | 0.300 |
Why?
|
| Iodide Peroxidase | 1 | 2024 | 23 | 0.220 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2024 | 42 | 0.220 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1304 | 0.200 |
Why?
|
| Thyrotropin | 2 | 2011 | 34 | 0.170 |
Why?
|
| Triiodothyronine | 2 | 2009 | 30 | 0.120 |
Why?
|
| Goiter, Substernal | 1 | 2014 | 2 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2014 | 29 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2014 | 81 | 0.100 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2011 | 27 | 0.090 |
Why?
|
| Immunoassay | 1 | 2011 | 70 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2011 | 197 | 0.090 |
Why?
|
| Thyroglobulin | 1 | 2010 | 9 | 0.080 |
Why?
|
| Iodine Radioisotopes | 1 | 2010 | 52 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 44 | 0.080 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2009 | 5 | 0.080 |
Why?
|
| Gluconeogenesis | 1 | 2009 | 15 | 0.080 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 15 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 278 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 372 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 230 | 0.080 |
Why?
|
| Point Mutation | 1 | 2009 | 166 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 502 | 0.070 |
Why?
|
| Metformin | 1 | 2009 | 73 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 701 | 0.070 |
Why?
|
| Humans | 6 | 2024 | 63283 | 0.070 |
Why?
|
| Heart | 2 | 2000 | 282 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 217 | 0.070 |
Why?
|
| Middle Aged | 1 | 2024 | 17535 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2009 | 410 | 0.060 |
Why?
|
| Male | 3 | 2024 | 29799 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 686 | 0.060 |
Why?
|
| Liver | 1 | 2009 | 851 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2460 | 0.060 |
Why?
|
| Mutation | 1 | 2011 | 2607 | 0.050 |
Why?
|
| Myocardium | 2 | 2000 | 274 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2011 | 5647 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2000 | 20 | 0.040 |
Why?
|
| Adenylyl Cyclases | 1 | 2000 | 21 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 1999 | 32 | 0.040 |
Why?
|
| Potassium Channels | 1 | 1999 | 58 | 0.040 |
Why?
|
| Gene Expression | 1 | 1999 | 839 | 0.030 |
Why?
|
| Aged | 1 | 2011 | 14384 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2014 | 31 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 129 | 0.030 |
Why?
|
| Hyperthyroidism | 2 | 2000 | 19 | 0.020 |
Why?
|
| Female | 1 | 2011 | 32776 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 43 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2009 | 80 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 174 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 102 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 619 | 0.020 |
Why?
|
| Animals | 4 | 2009 | 20634 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2009 | 347 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 937 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1592 | 0.020 |
Why?
|
| Rats | 2 | 2000 | 1977 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1990 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1276 | 0.020 |
Why?
|
| Mice | 2 | 2009 | 10827 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2000 | 1539 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 2000 | 2 | 0.010 |
Why?
|
| Colforsin | 1 | 2000 | 24 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2000 | 36 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2000 | 33 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 150 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2000 | 139 | 0.010 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 1999 | 1 | 0.010 |
Why?
|
| Half-Life | 1 | 1999 | 80 | 0.010 |
Why?
|
| Organ Size | 1 | 1999 | 172 | 0.010 |
Why?
|
| Reference Values | 1 | 1999 | 335 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 542 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 16771 | 0.010 |
Why?
|
| Time Factors | 1 | 1999 | 3757 | 0.010 |
Why?
|